Arenavirus Nucleoproteins Prevent Activation of Nuclear Factor Kappa B

ABSTRACT Arenaviruses include several causative agents of hemorrhagic fever (HF) disease in humans that are associated with high morbidity and significant mortality. Morbidity and lethality associated with HF arenaviruses are believed to involve the dysregulation of the host innate immune and inflammatory responses that leads to impaired development of protective and efficient immunity. The molecular mechanisms underlying this dysregulation are not completely understood, but it is suggested that viral infection leads to disruption of early host defenses and contributes to arenavirus pathogenesis in humans. We demonstrate in the accompanying paper that the prototype member in the family, lymphocytic choriomeningitis virus (LCMV), disables the host innate defense by interfering with type I interferon (IFN-I) production through inhibition of the interferon regulatory factor 3 (IRF3) activation pathway and that the viral nucleoprotein (NP) alone is responsible for this inhibitory effect (C. Pythoud, W. W. Rodrigo, G. Pasqual, S. Rothenberger, L. Martínez-Sobrido, J. C. de la Torre, and S. Kunz, J. Virol. 86:7728–7738, 2012). In this report, we show that LCMV-NP, as well as NPs encoded by representative members of both Old World (OW) and New World (NW) arenaviruses, also inhibits the nuclear translocation and transcriptional activity of the nuclear factor kappa B (NF-κB). Similar to the situation previously reported for IRF3, Tacaribe virus NP (TCRV-NP) does not inhibit NF-κB nuclear translocation and transcriptional activity to levels comparable to those seen with other members in the family. Altogether, our findings demonstrate that arenavirus infection inhibits NF-κB-dependent innate immune and inflammatory responses, possibly playing a key role in the pathogenesis and virulence of arenavirus.

[1]  S. Kunz,et al.  Arenavirus Nucleoprotein Targets Interferon Regulatory Factor-Activating Kinase IKKε , 2012, Journal of Virology.

[2]  M. Karin,et al.  TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2 , 2011, Proceedings of the National Academy of Sciences.

[3]  S. Kawabata,et al.  Mitochondria and antiviral innate immunity. , 2011, International journal of biochemistry and molecular biology.

[4]  J. C. de la Torre,et al.  The C-Terminal Region of Lymphocytic Choriomeningitis Virus Nucleoprotein Contains Distinct and Segregable Functional Domains Involved in NP-Z Interaction and Counteraction of the Type I Interferon Response , 2011, Journal of Virology.

[5]  N. Tordo,et al.  Lassa Virus Nucleoprotein Mutants Generated by Reverse Genetics Induce a Robust Type I Interferon Response in Human Dendritic Cells and Macrophages , 2011, Journal of Virology.

[6]  S. Becker,et al.  Tacaribe Virus but Not Junin Virus Infection Induces Cytokine Release from Primary Human Monocytes and Macrophages , 2011, PLoS neglected tropical diseases.

[7]  K. Conzelmann,et al.  The Measles Virus V Protein Binds to p65 (RelA) To Suppress NF-κB Activity , 2011, Journal of Virology.

[8]  Erica Ollmann Saphire,et al.  Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3′ to 5′ exonuclease activity essential for immune suppression , 2011, Proceedings of the National Academy of Sciences.

[9]  D. Kabelitz,et al.  Novel splice variants of human IKKε negatively regulate IKKε‐induced IRF3 and NF‐kB activation , 2011, European journal of immunology.

[10]  J. C. de la Torre,et al.  Use of Single-Cycle Infectious Lymphocytic Choriomeningitis Virus To Study Hemorrhagic Fever Arenaviruses , 2010, Journal of Virology.

[11]  H. Ly,et al.  Cap binding and immune evasion revealed by Lassa nucleoprotein structure , 2010, Nature.

[12]  P. Borrow,et al.  Inhibition of the Type I Interferon Antiviral Response During Arenavirus Infection , 2010, Viruses.

[13]  I. Frydas,et al.  Modulation of NF-kappaΒ signalling pathways by parasites. , 2010, Journal of biological regulators and homeostatic agents.

[14]  E. Kurt-Jones,et al.  Induction and Inhibition of Type I Interferon Responses by Distinct Components of Lymphocytic Choriomeningitis Virus , 2010, Journal of Virology.

[15]  A. Israël The IKK complex, a central regulator of NF-kappaB activation. , 2010, Cold Spring Harbor perspectives in biology.

[16]  T. Briese,et al.  Z Proteins of New World Arenaviruses Bind RIG-I and Interfere with Type I Interferon Induction , 2009, Journal of Virology.

[17]  D. Gorenstein,et al.  Attenuated and lethal variants of Pichindé virus induce differential patterns of NF-kappaB activation suggesting a potential target for novel therapeutics. , 2009, Viral immunology.

[18]  John Steel,et al.  Hemagglutinin-Pseudotyped Green Fluorescent Protein-Expressing Influenza Viruses for the Detection of Influenza Virus Neutralizing Antibodies , 2009, Journal of Virology.

[19]  D. Feldser,et al.  Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma , 2009, Nature.

[20]  J. Shapero,et al.  A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin. , 2009, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[21]  J. C. de la Torre,et al.  The Z Protein of the New World Arenavirus Tacaribe Virus Has Bona Fide Budding Activity That Does Not Depend on Known Late Domain Motifs , 2009, Journal of Virology.

[22]  A. García-Sastre,et al.  Identification of Amino Acid Residues Critical for the Anti-Interferon Activity of the Nucleoprotein of the Prototypic Arenavirus Lymphocytic Choriomeningitis Virus , 2009, Journal of Virology.

[23]  Shannon L. Taylor,et al.  Hantaan Virus Nucleocapsid Protein Binds to Importin α Proteins and Inhibits Tumor Necrosis Factor Alpha-Induced Activation of Nuclear Factor Kappa B , 2008, Journal of Virology.

[24]  T. Kaisho,et al.  Host-pathogen interactions. , 2008, Current opinion in immunology.

[25]  H. Ly,et al.  Genome comparison of virulent and avirulent strains of the Pichinde arenavirus , 2008, Archives of Virology.

[26]  J. Simons,et al.  A new arenavirus in a cluster of fatal transplant-associated diseases. , 2008, The New England journal of medicine.

[27]  G. Taylor,et al.  Bmc Structural Biology Crystal Structure of Human Ips-1/mavs/visa/cardif Caspase Activation Recruitment Domain , 2022 .

[28]  S. Ghosh,et al.  Shared Principles in NF-κB Signaling , 2008, Cell.

[29]  J. Hiscott Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response. , 2007, Cytokine & growth factor reviews.

[30]  A. García-Sastre,et al.  Differential Inhibition of Type I Interferon Induction by Arenavirus Nucleoproteins , 2007, Journal of Virology.

[31]  Rasha Hammamieh,et al.  Monkey Model for Lassa Fever Early Blood Profiles of Virus Infection in a Supplemental Material , 2007 .

[32]  G. Kochs,et al.  Multiple Anti-Interferon Actions of the Influenza A Virus NS1 Protein , 2007, Journal of Virology.

[33]  D. Gorenstein,et al.  Identification of Differentially Activated Cell-Signaling Networks Associated with Pichinde Virus Pathogenesis by Using Systems Kinomics , 2006, Journal of Virology.

[34]  J. Hiscott,et al.  Manipulation of the nuclear factor-κB pathway and the innate immune response by viruses , 2006, Oncogene.

[35]  A. García-Sastre,et al.  Inhibition of the Type I Interferon Response by the Nucleoprotein of the Prototypic Arenavirus Lymphocytic Choriomeningitis Virus , 2006, Journal of Virology.

[36]  K. Honda,et al.  Type I Inteferon Gene Induction by the Interferon Regulatory Factor Family of Transcription Factors , 2006 .

[37]  W. Romanow,et al.  IKK-i signals through IRF3 and NFkappaB to mediate the production of inflammatory cytokines. , 2006, Cellular signalling.

[38]  Qiang Sun,et al.  Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKε Molecular Complex from the Mitochondrial Outer Membrane by Hepatitis C Virus NS3-4A Proteolytic Cleavage , 2006, Journal of Virology.

[39]  Erica Ollmann Saphire,et al.  Ebola Virus VP35 Protein Binds Double-Stranded RNA and Inhibits Alpha/Beta Interferon Production Induced by RIG-I Signaling , 2006, Journal of Virology.

[40]  Arjun Srinivasan,et al.  Transmission of lymphocytic choriomeningitis virus by organ transplantation. , 2006, The New England journal of medicine.

[41]  J. Hiscott,et al.  MasterCARD: a priceless link to innate immunity. , 2006, Trends in molecular medicine.

[42]  T. Seya,et al.  The kinase complex responsible for IRF-3-mediated IFN-beta production in myeloid dendritic cells (mDC). , 2006, Journal of biochemistry.

[43]  Ralf Bartenschlager,et al.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.

[44]  Osamu Takeuchi,et al.  IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction , 2005, Nature Immunology.

[45]  Z. Zhai,et al.  VISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling , 2005 .

[46]  J. Muñoz-Jordán,et al.  Inhibition of Alpha/Beta Interferon Signaling by the NS4B Protein of Flaviviruses , 2005, Journal of Virology.

[47]  B. Williams,et al.  Analysis of Genes Induced by Sendai Virus Infection of Mutant Cell Lines Reveals Essential Roles of Interferon Regulatory Factor 3, NF-κB, and Interferon but Not Toll-Like Receptor 3 , 2005, Journal of Virology.

[48]  V. Rao,et al.  NAK is recruited to the TNFR1 complex in a TNFalpha-dependent manner and mediates the production of RANTES: identification of endogenous TNFR-interacting proteins by a proteomic approach. , 2004, The Journal of biological chemistry.

[49]  G. Kochs,et al.  Inverse interference: how viruses fight the interferon system. , 2004, Viral immunology.

[50]  J. C. de la Torre,et al.  Myristoylation of the RING Finger Z Protein Is Essential for Arenavirus Budding , 2004, Journal of Virology.

[51]  M. Georges-Courbot,et al.  Human Macrophages, but Not Dendritic Cells, Are Activated and Produce Alpha/Beta Interferons in Response to Mopeia Virus Infection , 2004, Journal of Virology.

[52]  I. Lukashevich,et al.  LCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regeneration , 2004, Archives of Virology.

[53]  G. Cheng,et al.  Differential Requirement for TANK-binding Kinase-1 in Type I Interferon Responses to Toll-like Receptor Activation and Viral Infection , 2004, The Journal of experimental medicine.

[54]  Osamu Takeuchi,et al.  The Roles of Two IκB Kinase-related Kinases in Lipopolysaccharide and Double Stranded RNA Signaling and Viral Infection , 2004, The Journal of experimental medicine.

[55]  W. Weissenhorn,et al.  Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). , 2004, Virus research.

[56]  Sonia Sharma,et al.  Convergence of the NF‐κB and Interferon Signaling Pathways in the Regulation of Antiviral Defense and Apoptosis , 2003, Annals of the New York Academy of Sciences.

[57]  M. Karin,et al.  Identification of NAP1, a Regulatory Subunit of IκB Kinase-Related Kinases That Potentiates NF-κB Signaling , 2003, Molecular and Cellular Biology.

[58]  Guo-Ping Zhou,et al.  Triggering the Interferon Antiviral Response Through an IKK-Related Pathway , 2003, Science.

[59]  G. Kochs,et al.  Viral evasion of the interferon system: old viruses, new tricks. , 2003, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[60]  I. Lukashevich,et al.  Arenavirus-Mediated Liver Pathology: Acute Lymphocytic Choriomeningitis Virus Infection of Rhesus Macaques Is Characterized by High-Level Interleukin-6 Expression and Hepatocyte Proliferation , 2003, Journal of Virology.

[61]  S. Lomvardas,et al.  Modifying Gene Expression Programs by Altering Core Promoter Chromatin Architecture , 2002, Cell.

[62]  A. García-Sastre Mechanisms of inhibition of the host interferon α/β-mediated antiviral responses by viruses , 2002 .

[63]  D. Creely,et al.  IKK-i and TBK-1 are Enzymatically Distinct from the Homologous Enzyme IKK-2 , 2002, The Journal of Biological Chemistry.

[64]  Amer A. Beg,et al.  Influenza A Virus NS1 Protein Prevents Activation of NF-κB and Induction of Alpha/Beta Interferon , 2000, Journal of Virology.

[65]  T. Mak,et al.  Deficiency of T2K leads to apoptotic liver degeneration and impaired NF‐κB‐dependent gene transcription , 2000, The EMBO journal.

[66]  Ali S Khan,et al.  Lymphocytic choriomeningitis virus: an underdiagnosed cause of congenital chorioretinitis. , 2000, American journal of ophthalmology.

[67]  M. Karin,et al.  NAK is an IκB kinase-activating kinase , 2000, Nature.

[68]  T. Maniatis,et al.  IKKε Is Part of a Novel PMA-Inducible IκB Kinase Complex , 2000 .

[69]  S. Akira,et al.  NF‐κB activation through IKK‐i‐dependent I‐TRAF/TANK phosphorylation , 2000, Genes to cells : devoted to molecular & cellular mechanisms.

[70]  W. O'brien,et al.  Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis. , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[71]  D. Baltimore,et al.  NF‐κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK‐related kinase , 1999, The EMBO journal.

[72]  I. Lukashevich,et al.  Lassa and mopeia virus replication in human monocytes/macrophages and in endothelial cells: Different effects on IL‐8 and TNF‐α gene expression , 1999, Journal of medical virology.

[73]  S. Akira,et al.  IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases. , 1999, International immunology.

[74]  T. Ksiazek,et al.  Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[75]  R. Rueckert Picornaviridae: The viruses and their replication , 1996 .

[76]  A. Ciechanover,et al.  Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[77]  J. Maiztegui,et al.  Increased tumor necrosis factor-alpha levels in Argentine hemorrhagic fever. , 1992, The Journal of infectious diseases.

[78]  Jahrling Pb,et al.  Lymphocytic choriomeningitis virus. A neglected pathogen of man. , 1992 .

[79]  T. H. Lee,et al.  Tumor necrosis factor acts synergistically with autocrine interferon-beta and increases interferon-beta mRNA levels in human fibroblasts. , 1989, The Journal of biological chemistry.

[80]  J. Huggins,et al.  Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever , 1988, Antimicrobial Agents and Chemotherapy.

[81]  N. Snell Ribavirin therapy for lassa fever. , 1988, The Practitioner.

[82]  J. McCormick,et al.  Therapeutic Effect of the Antiviral Agent Ribavirin in Junin Virus Infection of Primates , 1986, Journal of medical virology.

[83]  M. Saron,et al.  Chronic production of interferon in carrier mice congenitally infected with lymphocytic choriomeningitis virus. , 1982, Virology.

[84]  P. Jahrling,et al.  Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. , 1980, The Journal of infectious diseases.

[85]  J. Maiztegui,et al.  [Argentine hemorrhagic fever]. , 1978, Medicina.

[86]  K. Honda,et al.  Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. , 2006, Immunity.

[87]  Julia Romanova,et al.  Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18. , 2005, The Journal of general virology.

[88]  Z. Zhai,et al.  VISA is an adapter protein required for virus-triggered IFN-beta signaling. , 2005, Molecular cell.

[89]  L. Martínez Peralta,et al.  Lymphocytic choriomeningitis virus , 2005, Archives of Virology.

[90]  A. García-Sastre Identification and characterization of viral antagonists of type I interferon in negative-strand RNA viruses. , 2004, Current topics in microbiology and immunology.

[91]  P. Scheurich,et al.  Tumor necrosis factor signaling , 2003, Cell Death and Differentiation.

[92]  M. Karin,et al.  Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling. , 2003, Molecular and cellular biology.

[93]  T. Maniatis,et al.  IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. , 2003, Nature immunology.

[94]  C. Peters Human infection with arenaviruses in the Americas. , 2002, Current topics in microbiology and immunology.

[95]  A. García-Sastre Mechanisms of inhibition of the host interferon alpha/beta-mediated antiviral responses by viruses. , 2002, Microbes and infection.

[96]  M. Buchmeier,et al.  Arenaviridae: The viruses and their replication , 2001 .

[97]  P. Scheurich,et al.  Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling. , 2001, The international journal of biochemistry & cell biology.

[98]  T. Maniatis,et al.  IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex. , 2000, Molecular cell.

[99]  M. Karin,et al.  NAK is an IkappaB kinase-activating kinase. , 2000, Nature.

[100]  C. Hack,et al.  Proinflammatory cytokines and elastase-alpha-1-antitrypsin in Argentine hemorrhagic fever. , 1999, The American journal of tropical medicine and hygiene.

[101]  L. Barton Lymphocytic choriomeningitis virus: a neglected central nervous system pathogen. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[102]  P. Borrow,et al.  Mechanism of lymphocytic choriomeningitis virus entry into cells. , 1994, Virology.

[103]  P. Jahrling,et al.  Lymphocytic choriomeningitis virus. A neglected pathogen of man. , 1992, Archives of pathology & laboratory medicine.

[104]  J. McCormick,et al.  Antiviral effect of ribavirin on Junin virus replication in vitro. , 1986, Revista Argentina de microbiologia.

[105]  J. Maiztegui,et al.  Correlation between endogenous interferon and the clinical evolution of patients with Argentine hemorrhagic fever. , 1985, Journal of interferon research.

[106]  A. Anusz [Lassa fever]. , 1981, Pielegniarka i polozna.